Readiness review for biotech and healthtech founders

Build a company investors have compelling reasons to fund.

Identify what could strengthen your investment case, before fundraising pressure limits your options.

Take the free Steer by AmethIntel review. See your readiness score on screen straight away, and receive a customised, human-led action plan within 24 hours.

Begin your free review
About 5 minutes Score on screen immediately Human-led plan within 24 hours Free right now No obligation
Series A IP & BARRIERS DIFFERENTIATION PATHWAY VALUATION SCIENCE DILIGENCE-READY A-01 · FOUNDATION: YOUR SCIENCE A-02 · STRUCTURE: STEER STEER BY AMETHINTEL SERIES A CASE DWG 01 REV A

Your pace

Take your time.

This review is built to be worked through slowly. Each question explains why it matters before you answer it.

You can go back to any earlier answer, stop, and come back later. Your answers are saved as you go. You decide when to submit.

Behind every plan is a team that reads your answers, not a machine that scores them.

Timing

Start at a sensible pace.

It is never too early to start, and rarely too late to start properly.

If you expect to close a round in the next 12 to 18 months, this is a good time to look at what needs building: the protection around your technology, the evidence behind your claims, and the route to the customers who will pay for it.

If your runway is shorter, we will still look with you. Some work will have less time to mature, and we will say so plainly.

The foundations

The foundations investors will test.

We do not begin with your slides. We begin with the investment case behind them. The review explores five foundations.

  1. 1
    Defensibility

    What protects your advantage, and how difficult would it be for competitors to replicate it?

  2. 2
    Demonstrable difference

    What makes your product or technology better than the relevant alternatives, and what evidence supports that claim?

  3. 3
    A credible path to adoption

    Who uses it, who decides to buy it, who pays, and what must be demonstrated before adoption becomes realistic?

  4. 4
    A valuable market position

    Is your initial market reachable and commercially meaningful? Can you defend your position, capture value and expand?

  5. 5
    A plan built around milestones

    What will the next financing enable you to demonstrate, and how could those milestones strengthen your position for the next round?

A deck explains the investment case. It cannot replace it. Steer helps you see what needs strengthening before you present that case to investors.

The process

How Steer works.

  1. 1

    Answer at your pace

    Each question explains why it matters. Your answers are saved as you go.

    New here? Read the biotech users guide or the healthtech users guide.

  2. 2

    See your readiness score

    Your score appears on screen straight away, showing where your case looks strong, where further evidence may be needed, and where important questions remain open.

    You do not need an email address to see it.

  3. 3

    Receive your plan by email

    Within 24 hours, your customised plan arrives by email. It is written to be kept and returned to: the priorities in order, why each one matters to your investment case, and the evidence or work each may require.

    Every plan is reviewed by our team before it is sent.

  4. 4

    Decide what comes next

    Use the plan on your own, or talk it through with us if that would help. There is no obligation to engage us.

Our stance

What Steer is, and what it isn't.

Steer is

A structured look at the investment case behind your business: what supports it, what remains uncertain, and what deserves attention first.

A starting point. Your score is a structured starting point, not a verdict. The aim is to help you make better-informed decisions while you still have room to choose.

Steer isn't

A pitch-deck polishing service.

A funding prediction. It does not predict whether you will raise.

A sample

See what the plan looks like.

Your score is only the beginning. The plan is what you keep.

Illustrative exampleFictional company
  1. Readiness profile across the five foundations, with the areas that look strong and those that need evidence.
  2. Three prioritised actions, in order, each with the reason it matters to investors.
  3. The evidence or milestones suggested for each action, and what to decide first.

View a sample plan

Confidential information

Keep your invention details to yourself.

Please do not enter unpublished results, invention details or trade secrets in your answers. The review is designed to assess your strategic position without them.

Your score appears on screen without an email.

Read our privacy terms

Choose your review

Two reviews, the same steps.

Both follow the same process, with questions suited to your sector. If your company develops a therapy or biological product, choose biotech. If it builds technology, software or a diagnostic for clinical use, choose healthtech.

Biotech and therapeutics

For therapeutics, biotechnology and related life-science companies. The review examines IP and competitive protection, differentiation and evidence, the development pathway, clinical and regulatory considerations, and financing milestones.

Start the biotech review

Read the biotech users guide first

Healthtech, diagnostics and digital health

For digital health, medical technology, diagnostics and healthcare software companies. The review examines technology differentiation, defensibility, adoption by clinicians and buyers, commercial economics, market access and financing milestones.

Start the healthtech review

Read the healthtech users guide first

Questions founders ask

Straight answers.

Is the review free?

Yes, right now. The review and your plan are free for now. If that changes, we will tell you in advance.

Do I need an email to see my score?

No. Your score appears on screen straight away. An email address is needed only to send your plan.

Will I get only a score?

No. Your score appears on screen immediately. Within 24 hours, your plan arrives by email.

Does a high score mean I will raise successfully?

No. The review is a structured reading of your answers, not a funding prediction. Outcomes depend on the opportunity, the evidence, the team, the financing requirements and the investor market.

What if my score is low?

A lower score is a starting point for improvement, not a verdict on your company's potential. Your plan identifies the areas that may need attention and puts the priorities in order.

Will the review tell me what my company is worth?

No. It identifies factors that may strengthen or weaken your investment case. A defensible valuation requires company-specific evidence and analysis.

Do I need to disclose patents or confidential data?

You may be asked about your IP strategy and the status of your protection. You should not disclose invention details, unpublished results or trade secrets.

Do I have to hire you afterwards?

No. You can use the plan on your own. If you later want help implementing it, you can talk to us then. There is no obligation to purchase services.

When should I start?

Ideally, well before you need to raise. If you expect to close a round in 12 to 18 months, this is a useful time to identify the priorities that may take time to address.

Begin

Start with one question.

Build the investment case before you need to raise.

Begin your free review